Hadassah

Hadassah Receives $6.5 Million Grant to Create Translational Medicine Institute

Monday, Feb 2 2015

Left to right: Mark Addleman, Executive Director, Hadassah UK; Guilda Shamash, Past Chair, Hadassah UK; Melissa Kaplan, Director, Hadassah International; Sir Ian Gainsford, Hadassah UK Advisory Committee and Hadassah International Board of Directors; Prof. Tamar Peretz, Interim Director, HMO; Dr. Linda Greenwall, Hadassah UK Trustee; and Jean Jacque Roboh, Hadassah UK Trustee.

Hadassah is delighted to start the new year with the announcement of a $6,500,000 grant to the Hadassah Medical Organization (HMO) from the Wohl Legacy Foundation in the UK to create the Wohl Institute for Translational Medical Researchone of the foundation's medicine and arts 50th anniversary celebratory grants, commemorating 50 years of giving.

Prof. Tamar Peretz, Acting Director General of HMO, who traveled to London to participate in the awards ceremony, noted that translational medicine brings the benefits of science back to the patient, with better technology to create improved infrastructure. In contrast to 15 years ago when science was undertaken only in the university setting, with translational medicine, scientific and medical needs can be defined at the individual patient level, then transferred from the patient to the laboratory to find a solution. The research results then flow back to the patient. This process allows a quicker transfer of knowledge and clinical application, resulting in better quality patient care.

The new Wohl Centre for Translational Medicine at Hadassah will look particularly into how diseases begin and progress, the development of drugs for specific diseases, and how individual patients benefit from different treatments and drug regimens. Physician/researchers will especially focus their work on cancers, multi-genes, Parkinson's, ALS, and other degenerative diseases.

The trustees of The Wohl Legacy Foundation believe that investing in translational medicine is vital to developing the most effective therapies for these complex diseases. This new Institute at Hadassah will bolster the hospital's team of clinicians and biomedical researchers with access to open laboratory space and cutting-edge scientific technology. It is their belief that Hadassah will provide a dramatic stimulus to translational medicine, and will help meet global clinical needs. The award was given to Hadassah because its history is one of scientific development and it continues to generate the highest number of research papers emanating from one institution in Israel.

Maurice Wohl, a rabbi's son, was born and raised in London. His faith and upbringing played a huge part in the evolution of his philanthropy. Prior to Vivienne's death from cancer in 2005 at the age of 59, they decided to establish the Maurice and Vivienne Wohl Philanthropic Foundation as a reflection of their lifetime of philanthropic activity. Maurice died in 2007, at age 90. He was buried in Jerusalem next to his beloved wife.

At the awards ceremony on January 29th, along with the announcements of the grant recipients, the Wohl Lecture was delivered by His Excellency Matthew Gould, Britain's Ambassador to Israel. In his remarks, the Ambassador said: "It is a real honor to give the Wohl lecture in the philanthropy's 50th Anniversary year. I feel passionately that the Jewish community here can have a huge and positive impact on relations between Britain and Israel. Jewish philanthropy tied together with Israeli creativity has achieved amazing things in Israel, and is still doing so. Maurice and Vivienne Wohl were models for giving that makes a difference.”

Comments

From: Sherri on March 16, 2015
Great news, I am so proud of Hadassah and the work we do!
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Friday, Jan 13 2017

Saving Children in the Nick of Time at Hadassah

When a four-year-old, blue and critically ill, was rushed into the pediatric emergency room at Hadassah Hospital Mount Scopus, Dr. David Rekhtman, head of the ER, and his team deciphered that the child had somehow consumed methadone.

READ MORE ›
alt_text

Friday, Jan 13 2017

Peace in Sight: An Israeli, Palestinian, and Hadassah Australia Collaboration

St. John of Jerusalem Eye Hospital, in collaboration with Hadassah Medical Center, has received a €500,000 grant from the European Union to establish a genetic research unit to serve the Palestinian communities.

READ MORE ›
alt_text

Friday, Jan 13 2017

A Second Chance at Life, Thanks to Hadassah’s Heart Institute

A resident of a rural settlement called Dishon, established by Libyan Jewish immigrants in 1953, Eyal Amar, age 47, was rather young to suffer a devastating heart attack. Nevertheless, he did, but thanks to the courage and skill of the specialists at the Hadassah Medical Organization’s Heart Institute and their complex protocol to redesign his heavily damaged heart, Eyal is able to walk and breathe again.

READ MORE ›
alt_text

Tuesday, Jan 10 2017

From Locked Jaw to Osteoarthritis: Hadassah Discovery Leads to New Treatment

What began as a solution to locked jaw--temporomandibular joint (TMJ) disorder--has led to the creation of a novel non-opioid pharmaceutical candidate for the treatment of osteoarthritis pain, thanks to a Hadassah Medical Organization discovery and collaboration with colleagues at the Hebrew University and the Technion.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More